BMS1P4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.893600E-01
Normal-vs-Stage2
6.086600E-01
Normal-vs-Stage3
3.186400E-01
Normal-vs-Stage4
9.375800E-01
Stage1-vs-Stage2
4.004400E-01
Stage1-vs-Stage3
4.764300E-03
Stage1-vs-Stage4
4.748600E-01
Stage2-vs-Stage3
8.754400E-02
Stage2-vs-Stage4
1.105230E-01
Stage3-vs-Stage4
1.076620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.167600E-01
Normal-vs-AfricanAmerican
4.717400E-01
Normal-vs-Asian
3.898400E-01
Caucasian-vs-AfricanAmerican
6.501900E-02
Caucasian-vs-Asian
4.872000E-02
AfricanAmerican-vs-Asian
4.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.866000E-01
Normal-vs-Female
2.494200E-01
Male-vs-Female
8.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.449400E-01
Normal-vs-Age(41-60Yrs)
6.246200E-01
Normal-vs-Age(61-80Yrs)
5.842000E-01
Normal-vs-Age(81-100Yrs)
2.357000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.523600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.582200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.682600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.077600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.113200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.815200E-01
Normal-vs-Daily Drinker
4.621600E-01
Normal-vs-Weekly Drinker
4.903800E-01
Normal-vs-Occasional Drinker
4.652000E-01
Normal-vs-Social Drinker
9.760200E-01
Non Drinker-vs-Daily Drinker
2.153600E-01
Non Drinker-vs-Weekly Drinker
6.239600E-01
Non Drinker-vs-Occasional Drinker
2.498800E-01
Non Drinker-vs-Social Drinker
2.437600E-02
Daily Drinker-vs-Weekly Drinker
1.879780E-01
Daily Drinker-vs-Occasional Drinker
9.796000E-01
Daily Drinker-vs-Social Drinker
4.055600E-03
Weekly Drinker-vs-Occasional Drinker
2.184200E-01
Weekly Drinker-vs-Social Drinker
2.130400E-01
Occasional Drinker-vs-Social Drinker
6.919700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.738990E-01
Normal-vs-Grade 2
4.418400E-02
Normal-vs-Grade 3
9.471500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.447600E-01
Grade 1-vs-Grade 3
9.060300E-02
Grade 1-vs-Grade 4
1.738990E-01
Grade 2-vs-Grade 3
1.081430E-01
Grade 2-vs-Grade 4
4.418400E-02
Grade 3-vs-Grade 4
9.471500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.936000E-01
Normal-vs-NonDiabetic
5.451200E-01
Diabetic-vs-NonDiabetic
5.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.312600E-01
Normal-vs-NoPancreatitis
5.669600E-01
Pancreatitis-vs-NoPancreatitis
7.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.759000E-01
Normal-vs-N1
5.954200E-01
N0-vs-N1
9.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.396400E-01
Normal-vs-TP53-NonMutant
6.877000E-01
TP53-Mutant-vs-TP53-NonMutant
8.466300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
